Literature DB >> 11140638

Structural basis of IAP recognition by Smac/DIABLO.

G Wu1, J Chai, T L Suber, J W Wu, C Du, X Wang, Y Shi.   

Abstract

Apoptosis is an essential process in the development and homeostasis of all metazoans. The inhibitor-of-apoptosis (IAP) proteins suppress cell death by inhibiting the activity of caspases; this inhibition is performed by the zinc-binding BIR domains of the IAP proteins. The mitochondrial protein Smac/DIABLO promotes apoptosis by eliminating the inhibitory effect of IAPs through physical interactions. Amino-terminal sequences in Smac/DIABLO are required for this function, as mutation of the very first amino acid leads to loss of interaction with IAPs and concomitant loss of Smac/DIABLO function. Here we report the high-resolution crystal structure of Smac/DIABLO complexed with the third BIR domain (BIR3) of XIAP. Our results show that the N-terminal four residues (Ala-Val-Pro-Ile) in Smac/DIABLO recognize a surface groove on BIR3, with the first residue Ala binding a hydrophobic pocket and making five hydrogen bonds to neighbouring residues on BIR3. These observations provide a structural explanation for the roles of the Smac N terminus as well as the conserved N-terminal sequences in the Drosophila proteins Hid/Grim/Reaper. In conjunction with other observations, our results reveal how Smac may relieve IAP inhibition of caspase-9 activity. In addition to explaining a number of biological observations, our structural analysis identifies potential targets for drug screening.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11140638     DOI: 10.1038/35050012

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  219 in total

Review 1.  Viruses and apoptosis.

Authors:  B J Thomson
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

2.  A chicken-or-egg conundrum in apoptosis: which comes first? Ceramide or PKCdelta?

Authors:  Steven Grant; Sarah Spiegel
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 3.  Molecular mechanisms of irradiation-induced apoptosis.

Authors:  Lei Zhou; Rong Yuan; Lanata Serggio
Journal:  Front Biosci       Date:  2003-01-01

4.  The role of IAP antagonist proteins in the core apoptosis pathway of the mosquito disease vector Aedes aegypti.

Authors:  Hua Wang; Rollie J Clem
Journal:  Apoptosis       Date:  2011-03       Impact factor: 4.677

5.  Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer.

Authors:  Pablo E Vivas-Mejia; Cristian Rodriguez-Aguayo; Hee-Dong Han; Mian M K Shahzad; Fatma Valiyeva; Mineko Shibayama; Arturo Chavez-Reyes; Anil K Sood; Gabriel Lopez-Berestein
Journal:  Clin Cancer Res       Date:  2011-04-21       Impact factor: 12.531

6.  Lipid-conjugated Smac analogues.

Authors:  Ewa D Micewicz; Josephine A Ratikan; Alan J Waring; Julian P Whitelegge; William H McBride; Piotr Ruchala
Journal:  Bioorg Med Chem Lett       Date:  2015-09-08       Impact factor: 2.823

7.  The BIR domain of IAP-like protein 2 is conformationally unstable: implications for caspase inhibition.

Authors:  Hwain Shin; Martin Renatus; Brendan P Eckelman; Viviane A Nunes; Claudio A M Sampaio; Guy S Salvesen
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

8.  Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis.

Authors:  Sean L Petersen; Lai Wang; Asligul Yalcin-Chin; Lin Li; Michael Peyton; John Minna; Patrick Harran; Xiaodong Wang
Journal:  Cancer Cell       Date:  2007-11       Impact factor: 31.743

9.  Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.

Authors:  Domagoj Vucic; Matthew C Franklin; Heidi J A Wallweber; Kanad Das; Brendan P Eckelman; Hwain Shin; Linda O Elliott; Saloumeh Kadkhodayan; Kurt Deshayes; Guy S Salvesen; Wayne J Fairbrother
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

10.  Synergistic targeting of AML stem/progenitor cells with IAP antagonist birinapant and demethylating agents.

Authors:  Bing Z Carter; Po Yee Mak; Duncan H Mak; Yuexi Shi; Yihua Qiu; James M Bogenberger; Hong Mu; Raoul Tibes; Hui Yao; Kevin R Coombes; Rodrigo O Jacamo; Teresa McQueen; Steven M Kornblau; Michael Andreeff
Journal:  J Natl Cancer Inst       Date:  2014-02       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.